Global Chemotherapy Devices Market Worth Over USD 18.8

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
120
Global Chemotherapy Devices Market Worth Over USD 18.8 Billion By 2024: Zion Market Research

New York, NY, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Chemotherapy Devices Market by Product (Cannula, Pump, Catheter, and Others) and by End-User (Home Care, Clinics, and Hospitals): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024” . According to the report, the global  chemotherapy devices market  was valued at approximately USD 11.1 billion in 2017 and is expected to generate around USD 18.8 billion by 2024, growing at a CAGR of around 7.9% between 2018 and 2024.

Cancer is caused by uncontrolled and abnormal growth of cells. It can spread to other body parts and is one of the most fatal global diseases. Tobacco is responsible for around 33% of cancer cases worldwide. Poor diet, obesity, excessive alcohol consumption, and low physical activity are responsible for around 10% of cancer cases, exposure to environmental pollutants and ionizing radiation, infections, such as hepatitis B, hepatitis C, Epstein–Barr virus, human papillomavirus infection, and human immunodeficiency virus (HIV).

Browse through 62 Tables & 22 Figures spread over 110 Pages and in-depth TOC on “Global Chemotherapy Devices Market: By Types, Size, Share, Applications, Segments, Analysis and Forecast, 2017—2024”.

Request Free Sample Report of Global Chemotherapy Devices Market Report @ https://www.zionmarketresearch.com/sample/che...ces-market

Cancer can be treated by using several techniques, such as surgery, chemotherapy, radiation therapy, immunotherapy, hormonal therapy, targeted therapy, stem cell therapy, and precision medicine. Chemotherapy involves blocking the progress of cancerous cells. Sometimes, chemotherapy is also used to ease cancerous symptoms by reducing the pain causing tumors. Chemotherapy can be directed orally as a pill, injected into body cavities, veins, muscles, or the spinal fluid. Currently, mostly chemotherapy is directed intravenously though oral chemotherapy medications are gaining wide acceptance across the world. Chemotherapy drugs are normally given in cycles. The cycle contains specific days’ medication followed by a break and recovery time. A chemotherapy cycle typically continues for one to four weeks and is increased. Each chemotherapy course is diverse but usually consists of four to six sessions. According to the Cancer Research UK, cancer was caused almost 9.6 million deaths worldwide in 2018. Most cases of cancer can be averted by following a healthy diet with lots of whole grains, vegetables, fruits, avoiding smoking and too much alcohol, and getting timely vaccination against infectious diseases.

The rising occurrences of multiple cancer types, such as sarcoma, lung cancer, lymphoma, myeloma, and breast cancer, are likely to act as the major growth driver for the chemotherapy devices market globally. Cancer is the second prominent cause of death globally. Furthermore, growing stress on research and development in oncology and the rising demand for precise and biological drug therapies are likely to propel this market in the future. However, unwillingness showed by patients to undergo chemotherapy might limit the chemotherapy devices market globally.

Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbro...ces-market

The chemotherapy devices market is segmented into product and end-user. By product, this market is segmented into cannula, pump, catheter, and others. The end-user segment includes home care, clinics, and hospitals.

By region, this market includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Europe is an established chemotherapy devices market, due to the increasing geriatric population, growing government expenditure on chemotherapy procedures through the National Health Service (NHS), favorable reimbursement policies, the increasing patient awareness, and advanced and well-developed healthcare infrastructure.

Browse the full  “Chemotherapy Devices Market by Product (Cannula, Pump, Catheter, and Others) and by End-User (Home Care, Clinics, and Hospitals): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024”  Report at  https://www.zionmarketresearch.com/report/che...ces-market

North America is anticipated to display substantial growth in the near future. At the country level, the U.S. is the leading chemotherapy devices market in North America. The U.S. will progress at the highest CAGR in the projected timeframe. This growth can be attributed to the high occurrences of multiple types of cancers, the presence of advanced healthcare infrastructure, and the availability of skilled oncologists in the country.

The Asia Pacific chemotherapy devices market is expected to record the highest growth rate in the estimated time period. Japan, India, and China are projected to drive this regional chemotherapy devices market. This regional market’s growth is likely to be driven by the rise in the awareness regarding cancer diagnosis and treatment, huge consumption of tobacco and other cancer-causing agents, and the increase in the per capita healthcare spending of the population.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/ch...ces-market

The Latin American region is likely to record a swift rate of growth over the estimated time period, due to a huge patient pool, the rise in cancer prevalence, and rapid healthcare infrastructure growth. The Middle Eastern and African chemotherapy devices market is anticipated to witness a restricted rate of growth due to the shortage of skilled oncologists and absence of advanced infrastructure facilities in the region.

Some key players of the chemotherapy devices market include Baxter International Inc., B. Braun Melsungen AG, Advanced Chemotherapy Technologies, Becton, Dickinson and Company, Halyard Health, Terumo Corporation, Fresenius Kabi, Moog Inc., Smiths Group PLC, Zyno Medical, and Micrel Medical Devices S.A.

Request Customized Copy of Report @ https://www.zionmarketresearch.com/custom/3672

This report segments the global chemotherapy devices market as follows:

Global Chemotherapy Devices Market: By Product

  • Cannula
  • Pump
  • Catheter
  • Others

Global Chemotherapy Devices Market: By End-User

  • Home Care
  • Clinics
  • Hospitals

Global Chemotherapy Devices Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research Follow Us Twitter: https://twitter.com/zion_research

Blog: http://usindustrynews.com | http://europeindustrynews.com | http://zmrresearchnews.us | http://zmrnewsanalysis.com

Contact Us:

Joel John 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

K-12 Scholarship Foundation Opens Doors for Students Nationwide

Updated Category News Views 23

Educational opportunities shouldn't feel like a game of chance, yet that's often the reality for many families out there. The K-12 Scholarship Foundation is making a play to level the educational playing field. With scholarship applications now open in 32 states, and pre-registration available in 18 more—including the District of Columbia—this nonprofit aims to extend...

Continue Reading
Anchorage Home Sellers: Pricing Strategy Insights Revealed

Updated Category News Views 86

Understanding Anchorage's Real Estate Climate In the bustling world of Anchorage real estate, it's not what you hear nationally that counts—it's about reading the nuances of your own backyard. That’s the principal mantra disseminated by Real Estate Expert Gary Cox, affectionately known as the 'King', in his latest discourse with HelloNation. A pertinent perspective...

Continue Reading
Intoxalock's Breathalyzer Launch: Implications for Investors

Updated Category News Views 0

A One-Touch Solution in the DUI Landscape Kicking off today's market chatter, Intoxalock—the heavyweight in ignition interlock devices—is rolling out its sparkly new one-touch breathalyzer in the states of Pennsylvania and New Jersey. Now, these developments might not sound like Wall Street headliners at first glance, but don't blink; they've got teeth for those of us...

Continue Reading
Fibocom & Suntek Tackle Smart Lawn Mower Market

Updated Category News Views 14

Robotic Mowers Meet Tech Mastery In the never-ending quest to tech-up every corner of our lives, robotic mowers are carving out their patch of the market—thanks in no small part to Fibocom and Suntek teaming up like a couple of tech-savvy gardeners. Here’s the lowdown: In Munich, during the electronica 2026 show, these two companies showcased how they’re making...

Continue Reading
Obesity Diagnosis: Why BMI Falls Short, Fresh Insights

Updated Category News Views 68

Beyond BMI: Rethinking Obesity Diagnosis If you ever thought body mass index (BMI) was the ultimate measure of obesity, think again. A groundbreaking study, featuring over 844,000 adults and spanning four countries, pokes holes in that assumption and delivers a wake-up call on how we diagnose obesity and assess health risks. Led by King's College London, this research...

Continue Reading
HelloNation Elevates Contractors' Expertise at PHCC NC

Updated Category News Views 0

Times are changing, and the digital landscape keeps morphing—who can keep up? That's exactly what's on the agenda as McKenzie Finkhousen and Alton Baird lead HelloNation into the 2026 PHCC of NC Annual Meeting. This ain't just another LinkedIn meet-up—this is a proper gathering of minds in plumbing, heating, and cooling biz right at Harrah's Cherokee Casino Resort....

Continue Reading
HNCEXPO Shenzhen 2026: A Hub for Global Health Trends

Updated Category News Views 91

Spotlight on Health and Innovation at HNCEXPO In the bustling city of Shenzhen, where skyscrapers meet the sea, HNCEXPO 2026 wrapped up a colorful spectacle, leaving a vibrant impression on the health and nutrition industry. This isn't just any trade show—it's where global innovators gather to showcase the latest in nutraceuticals, dietary supplements, and smart senior...

Continue Reading
Huawei Shakes Up Home Energy With LUTERRA S2

Updated Category News Views 70

Welcome to the Future of Home Energy If you thought home energy systems couldn't get any slicker, Huawei's got news for you. They just dropped the LUTERRA S2, a swanky, all-in-one residential energy system that's about to put your old setup to shame. This ain’t your granddad's inverter. We're talking hybrid functionality with storage and AI-driven energy management...

Continue Reading
VTech's Revenue Jump: Profit Margins Slip Amid Cost Surge

Updated Category News Views 17

Charting VTech's Financial Waters Well, here we are – another chapter in the saga of VTech, the electronic learning product titan. This time, they've danced a jig of higher revenues, a sweet 5.6% jump to $1,046.9 million for the six months leading to September 2026. But hang on, the party's not all balloons and confetti. Profit margins? They're bobbing like a ship in a...

Continue Reading
ACR Poker's $20M OSS Series: A High-Stakes Arena

Updated Category News Views 79

The Big Poker Showdown Now, this is more like it. ACR Poker's $20 million guaranteed Online Super Series (OSS) is back in town, turning the virtual felt into a battlefield. We're talking a lineup that's more stacked than the chips at a high-stakes table. This series is running from November 8–24, and it's not just about the cash. They've thrown in over $77,000 in...

Continue Reading

Top 5 Most Recently Viewed Articles

CYIOS Corp. Appoints John O'Shea to Drive Future Growth

Updated Category News Views 248

CYIOS Corp. Welcomes John O’Shea as New CEO CYIOS Corp. (OTC: CYIO), a dynamic holding company focused on innovative and high-growth businesses in the medical and technology sectors, is excited to announce the appointment of John O'Shea as its Chief Executive Officer and Chairman of the Board. This decision marks a pivotal moment for the company as it aims to expand and...

Continue Reading
Navigating Managerial Transactions at Danske Bank: Key Updates

Updated Category News Views 191

Danske Bank A/S: Insights into Managerial Transactions In the realm of corporate finance, understanding transactions handled by individuals in key managerial roles is vital for transparency and investor confidence. Danske Bank A/S, a prominent financial institution, has recently notified relevant stakeholders regarding significant transactions made by those required to...

Continue Reading
Orgenesis Launches Trading on OTCQX Following Nasdaq Delisting

Updated Category News Views 66

Orgenesis Begins Trading on OTCQX Orgenesis Inc, a prominent player in the biotech sector dedicated to enhancing cell and gene therapies, has recently made a significant shift by commencing trading on the OTCQX Best Market under the ticker symbol "ORGS". This transition comes after the company faced delisting from the Nasdaq Stock Market due to not meeting the necessary...

Continue Reading
Class Action Against AMMO, Inc. for Securities Fraud Unfolds

Updated Category News Views 133

Overview of the Class Action Lawsuit The law firm Glancy Prongay & Murray LLP has launched a class action lawsuit concerning AMMO, Inc. (NASDAQ: POWW). This legal action is being pursued on behalf of investors who acquired AMMO securities during a specified period. The lawsuit was filed in the United States District Court for the District of Arizona and highlights...

Continue Reading
What to Expect from Saratoga Investment's Upcoming Earnings

Updated Category News Views 61

Saratoga Investment's Quarterly Earnings Anticipation Saratoga Investment (NYSE: SAR) is preparing to announce its upcoming quarterly earnings, which is generating a buzz among investors. With projections being an essential aspect of stock evaluations, this report is particularly important for those invested in the company. Analysts are forecasting that Saratoga...

Continue Reading